Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $597,507 | 332 | 99.9% |
| Food and Beverage | $367.00 | 22 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $597,507 | 332 | $0 (2024) |
| Bioventus LLC | $297.69 | 17 | $0 (2022) |
| FIDIA PHARMA USA INC. | $29.36 | 2 | $0 (2018) |
| Lilly USA, LLC | $24.06 | 2 | $0 (2017) |
| DePuy Synthes Sales Inc. | $15.89 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,832 | 42 | ABBVIE INC. ($27,832) |
| 2023 | $33,890 | 39 | AbbVie Inc. ($33,890) |
| 2022 | $33,490 | 24 | ABBVIE INC. ($33,473) |
| 2021 | $121,069 | 50 | AbbVie Inc. ($121,001) |
| 2020 | $81,745 | 44 | AbbVie Inc. ($81,692) |
| 2019 | $93,079 | 55 | AbbVie, Inc. ($92,931) |
| 2018 | $78,604 | 45 | AbbVie, Inc. ($78,592) |
| 2017 | $128,165 | 55 | AbbVie, Inc. ($128,096) |
All Payment Transactions
354 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $327.44 | General |
| 12/23/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $327.44 | General |
| 12/16/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 12/09/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 11/18/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 11/04/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 10/28/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 10/21/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 10/14/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 10/07/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 09/30/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 09/23/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 09/16/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 09/09/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 09/02/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 08/19/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 08/12/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $327.44 | General |
| 08/05/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 07/29/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 07/22/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 07/15/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 07/08/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 07/01/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
| 06/17/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,309.76 | General |
| 06/10/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $654.88 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 20 | 20 | $6,600 | $929.74 |
| 2022 | 4 | 80 | 193 | $44,733 | $5,136 |
| 2021 | 8 | 352 | 18,653 | $353,091 | $61,015 |
| 2020 | 10 | 434 | 12,476 | $360,591 | $59,251 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 20 | $6,600 | $929.74 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 39 | $12,207 | $2,283 | 18.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 16 | 29 | $23,865 | $1,517 | 6.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 17 | $7,905 | $1,268 | 16.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 12 | 108 | $756.00 | $67.44 | 8.9% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2021 | 18 | 17,304 | $86,520 | $28,925 | 33.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 65 | 197 | $154,997 | $11,302 | 7.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 96 | $41,760 | $8,537 | 20.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 113 | $33,335 | $7,535 | 22.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 38 | 38 | $16,340 | $2,700 | 16.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 73 | 872 | $6,104 | $759.76 | 12.4% |
| 73562 | X-ray of knee, 3 views | Office | 2021 | 12 | 18 | $6,325 | $655.77 | 10.4% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 13 | 15 | $7,710 | $599.59 | 7.8% |
| J7328 | Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 2020 | 15 | 10,920 | $43,680 | $17,581 | 40.2% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 74 | 204 | $149,298 | $11,655 | 7.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 106 | $44,215 | $8,375 | 18.9% |
| J7321 | Hyaluronan or derivative, hyalgan or supartz, for intra-articular injection, per dose | Office | 2020 | 12 | 121 | $37,873 | $7,515 | 19.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 83 | 113 | $31,753 | $5,854 | 18.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 54 | 54 | $21,978 | $3,903 | 17.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $10,336 | $2,031 | 19.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 83 | 900 | $6,300 | $936.61 | 14.9% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2020 | 13 | 20 | $9,740 | $935.48 | 9.6% |
| 73562 | X-ray of knee, 3 views | Office | 2020 | 11 | 21 | $5,418 | $466.01 | 8.6% |
About Dr. Gregory Crovetti, MD
Dr. Gregory Crovetti, MD is a Internal Medicine healthcare provider based in Mount Pleasant, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750311999.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Crovetti, MD has received a total of $597,874 in payments from pharmaceutical and medical device companies, with $27,832 received in 2024. These payments were reported across 354 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($597,507).
As a Medicare-enrolled provider, Crovetti has provided services to 886 Medicare beneficiaries, totaling 31,342 services with total Medicare billing of $126,331. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Emergency Medicine, Sports Medicine
- Location Mount Pleasant, WI
- Active Since 07/04/2006
- Last Updated 12/20/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1750311999
Products in Payments
- GELSYN 3 (Device) $185.86
- GELSYN-3 (Device) $84.88
- Exogen (Device) $26.95
- FORTEO (Drug) $24.06
- HYMOVIS (Device) $17.35
- MONOVISC (Device) $15.89
- Hymovis (Device) $12.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mount Pleasant
Dr. Ahmad Hakemi, Md, MD
Internal Medicine — Payments: $152,745
Dr. Joshua Watson, M.d, M.D
Internal Medicine — Payments: $8,352
Yvonne Davis, Md, MD
Internal Medicine — Payments: $4,585
Dr. Kimberly Davis-Seagle, M.d, M.D
Internal Medicine — Payments: $2,576
Mrs. Anna Morgan, M.d, M.D
Internal Medicine — Payments: $1,879
Dr. Jennifer Jane Carvin, M.d, M.D
Internal Medicine — Payments: $1,766